91麻豆精品国产综合久久久,人人玩人人添人人澡超碰,五月婷婷六月激情综合,国产一级二级三级久久

訂購信息
上海拜力生物科技公司
Tel:400-968-7988    021-33779008
TG101348(SAR302503),JAK2andBRD4DualInhibitor
品牌:Xcessbio
貨號:M60172-5s
規(guī)格:5 mg solid
貨期:

TG101348(SAR302503),JAK2andBRD4DualInhibitor

商品詳情 參考文獻 相關資料
Product Information
Molecular Weight: 524.68
Formula: C27H36N6O3S
Purity: ≥98%
CAS#: 936091-26-8
Solubility: DMSO up to 100 mM
Chemical Name: N-(tert-butyl)-3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide
Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

Biological Activity:
TG101348 is a potent, specific and orally bioavailable inhibitor of JAK2 (IC50 ~3 nM) and BRD4 (IC50 ~164 nM). It is 35- and 334-fold more selective for JAK2 versus JAK1 and JAK3. It also significantly inhibits JAK2 V617F, Flt3, and Ret with IC50 of 3 nM, 15 nM, and 48 nM, respectively. TG101348 induces apoptosis in both HEL and Ba/F3 JAK2V617F cells, but not in normal human dermal fibroblasts at concentrations up to 10 uM, and its antiproliferative IC50 against fibroblasts is > 5 uM. In a UT7/EPO cell line, TG101348 inhibited STAT5 phosphorylation at 600 nM and inhibited AKT phosphorylation while reducing GATA-1 S310 phosphorylation. It also displaces BRD4 from chromatin and suppresses c-Myc expression. The combination of inhibitory activities on independent kinase and bromodomain oncogenic pathways exemplifies a new strategy for rational single-agent polypharmacological targeting.


How to Use:

  • In vitro: TG101348 was used at 1 μM in vitro.
  • In vivo: TG101348 was dosed to mice orally at 120 mg/kg twice per day in xenograft models.


Reference:

  1. 1. Wernig G, et al. Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. (2008) Cancer Cell. 13(4):311-20.
  2. 2. Geron I, et al. Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors. (2008) Cancer Cell. 13(4):321-30.
  3. 3. Lasho T, et al. Inhibition of JAK-STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells. (2010) Leukemia. 24(7):1378-80.
  4. 4. Ciceri P, et al. Dual kinase-bromodomain inhibitors for rationally designed polypharmacology. (2014) Nat Chem Biol. In press.



Products are for research use only. Not for human use.

熱銷產(chǎn)品
熱銷產(chǎn)品排行榜
  • 關于我們
  • 購物流程
  • 支付方式
  • 配送方式

請打開QQ掃碼聯(lián)系
Copyright@ 2003-2024  進口試劑采購網(wǎng)版權所有     

BIOLEAF熱搜   BIOLEAF試劑盒   BIOLEAF ELISA   BIOLEAF試劑   BIOLEAF品牌   BIOLEAF抗體   BIOLEAF耗材   BIOLEAF小儀器

sitemap   細胞庫查詢   危險品圖標

本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研!

         滬ICP備08023583號-6     
產(chǎn)品咨詢
QQ掃碼溝通
在線客服
服務電話
400-968-7988
掃碼關注
微信公眾號二維碼

滬公網(wǎng)安備 31011202007338號

河北区| 安宁市| 登封市| 恩施市| 长汀县| 筠连县| 梁平县| 信阳市| 泰和县| 冕宁县| 济南市| 登封市| 六枝特区| 衡阳县| 石家庄市| 昌乐县| 延吉市| 五莲县| 博客| 华池县| 临漳县| 赫章县| 马龙县| 林西县| 洛扎县| 秀山| 河西区| 循化| 曲靖市| 广东省| 五大连池市| 定结县| 四子王旗| 神木县| 梁河县| 兰坪| 南充市| 庄河市| 济阳县| 陆川县| 加查县|